首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >New 3-(4-(aryl)piperazin-1-yl)-1-(benzo(b)thiophen-3-yl)propane derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants.
【24h】

New 3-(4-(aryl)piperazin-1-yl)-1-(benzo(b)thiophen-3-yl)propane derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants.

机译:新的3-(4-(芳基)哌嗪-1-基)-1-(苯并(b)噻吩-3-基)丙烷衍生物对5-HT1A血清素受体和血清素转运蛋白具有双重作用,是一类新型的抗抑郁药。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of new 3-[4-(aryl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)propane derivatives were synthesized in an attempt to find a new class of antidepressant drugs with dual activity at 5-HT1A serotonin receptors and serotonin transporter. Title compounds were evaluated for in vitro activity on 5-HT1A receptor and 5-HT transporter. They show high nanomolar affinity for both activities, and in particular, compounds 1-(5-chlorobenzo[b]thiophen-3-yl)-3-[4-(2-methoxyphenyl)piperazin-1-yl]propan-1-ol (7) and 1-(5-fluorobenzo[b]thiophen-3-yl)-3-[4-(2-methoxyphenyl)piperazin-1-yl]propan-1-ol (8) show values (nM) of K(i)=30 and 2.3 for 5-HT1A receptors and K(i)=30 and 12 for serotonin transporters, respectively. In GTPgammaS binding assays, compound 8 revealed antagonist properties to 5-HT1A receptors. Such a pharmacological profile could lead to potent antidepressant agents with new dual mechanism of action.
机译:为了寻找具有双重活性的新型抗抑郁药,合成了一系列新的3- [4-(芳基)哌嗪-1-基] -1-(苯并[b]噻吩-3-基)丙烷衍生物。在5-HT1A血清素受体和血清素转运蛋白。评价了标题化合物对5-HT1A受体和5-HT转运蛋白的体外活性。它们对两种活性都显示出高的纳摩尔亲和力,特别是化合物1-(5-氯苯并[b]噻吩-3-基)-3- [4-(2-甲氧基苯基)哌嗪-1-基]丙烷-1- ol(7)和1-(5-氟苯并[b]噻吩-3-基)-3- [4-(2-甲氧基苯基)哌嗪-1-基]丙-1-醇(8)显示值(nM) 5-HT1A受体的K(i)= 30和2.3,5-羟色胺转运蛋白的K(i)= 30和12。在GTPgammaS结合测定中,化合物8揭示了对5-HT1A受体的拮抗特性。这种药理作用可能导致具有新的双重作用机制的有效抗抑郁药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号